EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor

Term ID

CHEBI:145814

Synonyms

ASA dehydrogenase inhibitor
ASA dehydrogenase inhibitors
aspartate semialdehyde dehydrogenase inhibitor
aspartate semialdehyde dehydrogenase inhibitors
aspartate-semialdehyde dehydrogenase (EC 1.2.1.11) inhibitor
aspartate-semialdehyde dehydrogenase (EC 1.2.1.11) inhibitors
aspartate-semialdehyde dehydrogenase inhibitor
aspartate-semialdehyde dehydrogenase inhibitors
aspartic beta-semialdehyde dehydrogenase inhibitor
aspartic beta-semialdehyde dehydrogenase inhibitors
aspartic semialdehyde dehydrogenase inhibitor
aspartic semialdehyde dehydrogenase inhibitors
EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitors
EC 1.2.1.11 inhibitor
EC 1.2.1.11 inhibitors
L-aspartate-4-semialdehyde:NADP+ oxidoreductase (phosphorylating) inhibitor
L-aspartate-4-semialdehyde:NADP+ oxidoreductase (phosphorylating) inhibitors
L-aspartate-beta-semialdehyde:NADP oxidoreductase (phosporylating) inhibitor
L-aspartate-beta-semialdehyde:NADP oxidoreductase (phosporylating) inhibitors

(all 19)

Definition

Any EC 1.2.1.* (oxidoreductase acting on donor aldehyde/oxo group with NAD(+) or NADP(+) as acceptor) inhibitor that inhibits the action of aspartate-semialdehyde dehydrogenase (EC 1.2.1.11).

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: EC 1.2.1.* (oxidoreductase acting on donor aldehyde/oxo group with NAD(+) or NADP(+) as acceptor) inhibitor

EC 1.2.1.* (oxidoreductase acting on donor aldehyde/oxo group with NAD(+) or NADP(+) as acceptor) inhibitor Show first 5 Terms
inverse has_role: D-cystine L-cystine

D-cystine L-cystine Show first 5 Terms

Phenotype

Phenotype resulting from EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor

Phenotype where environments contain EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor

Phenotype modified by environments containing EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor

Phenotype affecting EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor

Human Disease Model